SCN1A and juvenile myoclonic epilepsy: In an earlier study on the same population we reported that a synonymous variant in GABRG2 rs211037 and SCN1A rs3812718 may have a putative role in increasing the risk of epilepsy, which was independent of its phenotype, that is, MTLE-HS or Juvenile myoclonic epilepsy [23], [57].